Vinglycinate
| Code | Size | Price |
|---|
| TAR-T35058-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Vinglycinate is a biochemical.
CAS:
865-24-7
Formula:
C48H63N5O9
Molecular Weight:
854.058
Purity:
0.98
SMILES:
CC[C@]1(O)C[C@@H]2CN(C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(=O)CN(C)C)[C@]1(O)C(=O)OC
References
Johnson IS, Hargrove WW, Harris PN, Wright HF, Boder GB. Preclinical studies with vinglycinate, one of a series of chemically derived analogs of vinblastine. Cancer Res. 1966 Dec;26(12):2431-6. PubMed PMID: 5955595.
Armstrong JG, Dyke RW, Fouts PJ, Hawthorne JJ, Jansen CJ Jr, Peabody AM. Initial clinical experience with vinglycinate sulfate, a molecular modification of vinblastine. Cancer Res. 1967 Feb;27(2):221-7. PubMed PMID: 5335120.